Source:http://linkedlifedata.com/resource/pubmed/id/16084942
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2005-8-8
|
pubmed:abstractText |
Fascin-1 is an actin-bundling protein that plays an important role in cell motility and adhesion. The level of fascin-1 is low or undetectable in normal epithelial cells. However, overexpression is reported in transformed epithelial cells and in several common types of carcinomas [Bioessays. 2002;24:359-361]. Up-regulation of fascin-1 is associated with higher grades and with aggressive tumors with poorer prognoses. We found no report on the role or the protein expression of fascin-1 in urothelial carcinomas (UCs) of the urinary bladder. In this study, we examined by immunohistochemistry the expression of fascin-1 in the normal human transitional epithelium, benign vesical lesions, and different types of UCs. We found no detectable fascin-1 in the normal transitional epithelium. There was no increase of fascin-1 expression in cystitis cystica, cystitis glandularis, nephrogenic adenoma (n = 10), inverted papilloma (n = 5), and classic exophytic papilloma (n = 4) or in adjacent transitional epithelia associated with these conditions. Patchy or diffusely weak fascin-1 expression was observed in 42% (5/12) of superficial papillary UCs (Ta), and 95% (19/20) of invasive UCs (T2 or higher) demonstrated diffuse strong staining for fascin-1. The microinvasive foci in the lamina propria of UC (T1, n = 8) were also positive for fascin-1, although they were not as strongly stained as in the deeply invasive tumors. Interestingly, the neoplastic cells in the tips of microinvasive carcinomas were distinctly positive for fascin-1. There were significant numbers of fascin-1-positive cells (>50% of the neoplastic cells) in UCs in situ (n = 10). These findings suggest an association between increased fascin-1 expression and increased invasiveness of carcinomas in the urinary bladder.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0046-8177
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
36
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
741-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16084942-Adult,
pubmed-meshheading:16084942-Aged,
pubmed-meshheading:16084942-Aged, 80 and over,
pubmed-meshheading:16084942-Carcinoma, Papillary,
pubmed-meshheading:16084942-Carcinoma, Transitional Cell,
pubmed-meshheading:16084942-Carrier Proteins,
pubmed-meshheading:16084942-Female,
pubmed-meshheading:16084942-Humans,
pubmed-meshheading:16084942-Immunoenzyme Techniques,
pubmed-meshheading:16084942-Male,
pubmed-meshheading:16084942-Microfilament Proteins,
pubmed-meshheading:16084942-Middle Aged,
pubmed-meshheading:16084942-Neoplasm Invasiveness,
pubmed-meshheading:16084942-Tumor Markers, Biological,
pubmed-meshheading:16084942-Urinary Bladder Neoplasms
|
pubmed:year |
2005
|
pubmed:articleTitle |
Fascin-1 expression in papillary and invasive urothelial carcinomas of the urinary bladder.
|
pubmed:affiliation |
Department of Pathology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA. gt2125@columbia.edu
|
pubmed:publicationType |
Journal Article
|